Abstract:Basic and acidic fibroblast growth factor (bFGF and aFGF, respectively) and vascular endothelial growth factor (VEGF) exert angiogenic actions and have a role in wound healing, inflammation, and tumor growth. Monocytes and endothelial cells are involved in these processes, but the effect of FGF and VEGF on monocyte-endothelial cell interactions has not been defined. We observed that monocyte adhesion to resting or cytokine (tumor necrosis factor-alpha or interleukin-1 alpha)-stimulated human umbilical vein endothelial cells (HUVECs) was markedly inhibited (40 to 65%) by culture (1 to 6 days) of HUVECs with aFGF or bFGF. Monocyte transendothelial migration induced by C5a and chemokines (MCP-1, SDF-1 alpha, RANTES, MIP-1 alpha) was also suppressed (by 50 to 75%) on bFGF-stimulated HUVECs. VEGF did not have these effects at the concentrations used (10 to 20 ng/ml), although like bFGF, it promoted HUVEC proliferation. Culture of HUVECs with bFGF and aFGF significantly down-regulated intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression on resting or tumor necrosis factor-alpha-stimulated HUVECs, but had no influence on platelet endothelial cell adhesion molecule (PECAM)-1 and VE-cadherin expression. bFGF also inhibited MCP-1 production by HUVECs. The inhibitory effects of bFGF on monocyte transendothelial migration and adhesion molecule expression were reversed by SU6668, an anti-angiogenic agent and bFGF receptor tyrosine kinase inhibitor. Our results suggest that bFGF and aFGF may suppress endothelial-dependent monocyte recruitment and thus have an anti-inflammatory action during angiogenesis in chronic inflammation but inhibit the immunoinflammatory tumor defense mechanism. However, SU6668 is an effective agent to prevent this down-regulatory action of bFGF on monocyte-endothelial cell interactions.

The Chemokine SDF-1 Α Suppresses Fibronectin-mediated in Vitro Lymphocytes Adhesion

The ability of SDF-1/CXCR4 axis to proliferation adhesion and invasion of small lung cancer cell

[Stem Cell Factor Enhances the Adhesion of Hematopoietic Cells to Fibronectin].

TNF-α inhibits SDF-1α secretion in cultured fibroblasts through activating NF-kappaB signaling pathway

Attachment of C-terminus of SDF-1 Enhances the Biological Activity of Its N-terminal Peptide.

Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668

C-terminal Peptides of Chemokine-Like Factor 1 Signal Through Chemokine Receptor CCR4 to Cross-Desensitize the CXCR4.

Loss of C-terminal Alpha-Helix Decreased SDF-1alpha-mediated Signaling and Chemotaxis Without Influencing CXCR4 Internalization.

SDF-1/54-DCN: a novel recombinant chimera with dual inhibitory effects on proliferation and chemotaxis of tumor cells.

The molecular mechanism of CXCR4/SDF-1 in tumor signal transduction

Chemokine-chemokine Receptor Pathway As a Tumor Therapeutic Target: the Significance of SDF-1CXCR4 Pair

Activin A As A Novel Chemokine Induces Migration Of L929 Fibroblasts By Erk Signaling In Microfluidic Devices

Distinct Chemokine Signaling Regulates Integrin Ligand Specificity to Dictate Tissue-Specific Lymphocyte Homing.

[Biological Behavior of Stromal Cell-Derived Factor-1 on Migration, Adhesion and Apoptosis in Different Kinds of AML Cell Lines].

CD99-Derived Agonist Ligands Inhibit Fibronectin-Induced Activation of β1 Integrin through the Protein Kinase A/SHP2/Extracellular Signal-Regulated Kinase/PTPN12/Focal Adhesion Kinase Signaling Pathway

[Tgf-Beta 1 Rapidly Reduced Hepatocarcinoma Cells Adhesion on to Fibronectin and Stimulated FAK Dephosphorylation].

The Structure and Function of SDF-1 and Its Receptor CXCR4

[Study of Biological Behavior of Stromal Cell-Derived Factor-1 on Multiple Myeloma Cell Migration and Adhesion].

Effect of Stromal Cell-Derived Factor-1α on Rat Vascular Smooth Muscle Cells/Monocytes Adhesion

Shear force-induced activation of integrin LFA-1 by chemokine CXCL12 under flows

BASIC RESEARCH SDF1/CXCR4 Signalling Promotes Mobility of Myeloma Cells by Activation and Redistribution of Cell Surface Adhesion Molecules